Tag: GlaxoSmithKline

All

Positive Phase III Data for GSK RSV Vaccine Candidate

A phase III trial investigating the GSK RSV vaccine candidate for adults aged 60 years and above exceeded its primary endpoint with no unexpected safety concerns observed, the company announced.

Monoclonal Antibody Sotrovimab No Longer Authorized in Northeastern US
GSK and Medicago’s Plant-based Covifenz Vaccine Approved in Canada
Sanofi-GSK Vaccine 100% Effective in Preventing Against Severe COVID-19, Hospitalizations
Philip Morris’ Battle to Buy Asthma Drugmaker Vectura
GSK Recalls Children’s Cough Syrup
GSK Says There’s No Link Between Pandemic H1N1 Flu Vaccine and Sleep Disorder
GSK Grants Will Support ATS COVID-19 Crisis Fund

All

FDA Questions Efficacy of GSK’s Nucala for COPD

US regulatory advisors are questioning the effectiveness of GlaxoSmithKline’s biologic Nucala as a...

Childhood Asthma: Arnuity Ellipta Approved for Kids 5-and-older
Triple Therapy More Effective for COPD than Dual Inhalers?
COPD Triple-combo Therapy Gets Expanded Indication
GlaxoSmithKline Lung Drug Anoro Approved In Europe
Anoro Ellipta Available In US For Treatment Of COPD
GSK Completes Enrollment for Landmark COPD-CVD Study

All

First Non-inhaled Treatment for Severe Asthma Shows Promise

GlaxoSmithKline reported positive results from 2 phase-III clinical trials for mepolizumab, a new treatment for severe eosinophilic asthma. If the drug were to receive FDA approval, it would become the first non-inhaled treatment for severe asthma.

Four Respiratory Drugs on Pathway to CE Approval

Tag: GlaxoSmithKline

All

All

All

Sorry, No Posts Found